SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-182856
Filing Date
2024-07-23
Accepted
2024-07-23 16:01:52
Documents
13
Period of Report
2024-07-19
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d858010d8k.htm   iXBRL 8-K 24141
  Complete submission text file 0001193125-24-182856.txt   145710

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eq-20240719.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20240719_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20240719_pre.xml EX-101.PRE 11262
16 EXTRACTED XBRL INSTANCE DOCUMENT d858010d8k_htm.xml XML 3668
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38692 | Film No.: 241134462
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)